Fortrea Holdings Inc

FTRE

Equity

ISIN null / Valor 127734378

NASDAQ (2026-10-07)

USD 20.56-1.06%

Fortrea Holdings Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Fortrea Holdings Inc. operates as a global provider in the healthcare sector, specializing in a wide range of services that support the lifecycle of clinical trials from Phase I through IV. The company's offerings encompass clinical pharmacology, patient access solutions, and other essential services aimed at facilitating the development and delivery of healthcare innovations. Fortrea distinguishes itself by partnering with both emerging and established biopharmaceutical, as well as medical device and diagnostic companies, leveraging its expertise to advance healthcare solutions worldwide. With a workforce of over 19,000 professionals, Fortrea is committed to delivering customized clinical trial solutions through three primary delivery models: full service, functional service provision, or a hybrid approach. This tailored strategy enables the company to meet the diverse needs of its clients across nearly 100 countries, underscoring its role as a key player in driving global healthcare innovation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

121%1Y

-24.2%3Y

%5Y

Performance

73.3%1Y

73.3%3Y

72.1%5Y

Volatility

1955 M

Market cap (USD)

2,245,344

Daily traded volume (Shares)

19.1 / 18.34

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

3.00

Innovation:

4.00

Society:

2.00

Nature:

2.00

Maryam Jaouad

UK, 06 Nov 2025

Fortrea Holdings shows solid performance in the clinical research sector, with growing contracts and steady innovation in drug development support. However, its ESG and sustainability efforts remain limited, and growth is still stabilizing after the recent spin-off.

EQUITIES OF THE SAME SECTOR

BACHEM HOLDING LTD